RETRACTION: Laparoscopic Hyperthermic Intraperitoneal Perfusion Chemotherapy for Patients With Malignant Ascites Secondary to Unresectable Gastric Cancer (Retraction of Vol 30, Pg 55, 2020)

被引：0
|
作者：
Ba, M-C
Long, H.
Zhang, X-L
机构：
来源：
SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES | 2021年 / 31卷 / 01期
关键词：
D O I：
10.1097/SLE.0000000000000911
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：133 / 133
页数：1
相关论文
共 50 条
  • [1] Laparoscopic Hyperthermic Intraperitoneal Perfusion Chemotherapy for Patients with Malignant Ascites Secondary to Unresectable Gastric Cancer
    Ba, Ming-chen
    Long, Hui
    Zhang, Xiang-Liang
    Gong, Yuan-Feng
    Tang, Yun-Qiang
    Wu, Yin-Bing
    Yu, Fei-Hong
    Cui, Shu-Zhong
    JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES, 2016, 26 (01): : 32 - 39
  • [2] RETRACTED: Laparoscopic Hyperthermic Intraperitoneal Perfusion Chemotherapy for Patients With Malignant Ascites Secondary to Unresectable Gastric Cancer (Retracted Article)
    Ba, Ming-Chen
    Long, Hui
    Zhang, Xiang-Liang
    Gong, Yuan-Feng
    Tang, Yun-Qiang
    Wu, Yin-Bing
    Yu, Fei-Hong
    Cui, Shu-Zhong
    SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES, 2020, 30 (01): : 55 - 61
  • [3] Hyperthermic intraperitoneal perfusion chemotherapy and response evaluation in patients with gastric cancer and malignant ascites
    Ni, Xuefeng
    Wu, Ping
    Wu, Jun
    Ji, Mei
    Tian, Bo
    Jiang, Zhenxing
    Sun, Yue
    Xing, Xiaoxiao
    Jiang, Jingting
    Wu, Changping
    ONCOLOGY LETTERS, 2017, 14 (02) : 1691 - 1696
  • [4] Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of malignant ascites secondary to unresectable peritoneal carcinomatosis from advanced gastric cancer
    Facchiano, E.
    Scaringi, S.
    Kianmanesh, R.
    Sabate, J. M.
    Castel, B.
    Flamant, Y.
    Coffin, B.
    Msika, S.
    EJSO, 2008, 34 (02): : 154 - 158
  • [5] Clinical efficacy of hyperthermic intraperitoneal chemotherapy on the malignant ascites in gastric cancer patients following the preoperative radiotherapy
    Wang, Z.
    Wang, P.
    Lv, L.
    Liu, Y.
    Sun, C. J.
    INTERNATIONAL JOURNAL OF RADIATION RESEARCH, 2022, 20 (04): : 865 - 869
  • [6] Hyperthermic Intraperitoneal Perfusion Chemotherapy and Cytoreductive Surgery for Controlling Malignant Ascites From Ovarian Cancer
    Ba, Mingchen
    Long, Hui
    Zhang, Xiangliang
    Tang, Yunqiang
    Wu, Yinbing
    Wang, Shuai
    Yan, Zhaofei
    Zhang, Bohuo
    Cui, Shuzhong
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 (09) : 1571 - 1579
  • [7] RETRACTION: Paradox in melanoma: more patients fewer publications (vol 30, pg 632, 2020) (Retraction of Vol 30, Pg 632, 2020)
    Tas, F.
    Erturk, K.
    MELANOMA RESEARCH, 2020, 30 (06) : 632 - 632
  • [8] Multivariate comparison of B-ultrasound guided and laparoscopic continuous circulatory hyperthermic intraperitoneal perfusion chemotherapy for malignant ascites (vol 27, pg 2735, 2013)
    Ba, Ming-Chen
    Long, Hui
    Cui, Shu-Zhong
    Tang, Yun-Qiang
    Wu, Yin-Bing
    Zhang, Xiang-Liang
    Tang, Hong-Sheng
    Bai, Sai-Xi
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2014, 28 (04): : 1401 - 1401
  • [9] Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for refractory malignant ascites in patients unsuitable for cytoreductive surgery
    Valle, S. J.
    Alzahrani, N. A.
    Alzahrani, S. E.
    Liauw, W.
    Morris, D. L.
    INTERNATIONAL JOURNAL OF SURGERY, 2015, 23 : 176 - 180
  • [10] Clinical study on intraperitoneal hyperthermic perfusion chemotherapy far patients with gastric cancer
    Cao, XF
    Wu, WM
    Qiu, HY
    Wu, BC
    Cai, MH
    Za, WZ
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S140 - S140
12345